Related Experiment Video

Updated: Jan 4, 2026

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System
09:16

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Published on: November 8, 2017

10.6K

CRISPR Cas9 in Pancreatic Cancer Research

Hai Yang1, Peter Bailey1, Christian Pilarsky1

  • 1Department for Surgical Research, Universitätsklinikum Erlangen, Erlangen, Germany.

Frontiers in Cell and Developmental Biology
|November 5, 2019
PubMed

Insights

CRISPR/Cas9 gene editing offers a promising new approach for pancreatic cancer research and targeted therapy. This technology can selectively target key drivers, potentially improving treatment outcomes for this deadly disease.

Area of Science:

  • Oncology
  • Genetics
  • Biotechnology

Background:

  • Pancreatic cancer is a leading cause of cancer death with stagnant survival rates.
  • Current treatments like surgery, radiation, and chemotherapy have limited efficacy.
  • Novel therapeutic strategies are urgently needed.

Purpose of the Study:

  • To review advances in CRISPR/Cas9 gene editing technology.
  • To explore the application of CRISPR/Cas9 in pancreatic cancer research.
  • To highlight its potential for targeted therapy.

Main Methods:

  • Review of current CRISPR/Cas9 technology.
  • Analysis of CRISPR/Cas9 applications in pancreatic cancer models.
  • Identification of key pancreatic cancer drivers targeted by CRISPR/Cas9.

Main Results:

  • CRISPR/Cas9 is a powerful tool for gene editing and functional genomics.
  • It enables precise manipulation of genes involved in pancreatic cancer.
  • Potential for developing targeted therapies against specific cancer drivers.

Conclusions:

  • CRISPR/Cas9 technology shows significant promise for advancing pancreatic cancer research.
  • Its application in targeted therapy could lead to more effective treatments.
  • Further research is warranted to translate CRISPR/Cas9 into clinical practice.
Keywords:
CRISPR/Cas9gene editingknock out and knock inlibrary screeningpancreatic cancer

More Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

13.6K
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

630

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.5K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.6K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.2K